Evidence map›Paper›PMID 28513805›Full record

ArticleJournal of Crohn's & colitis2017

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.

Marcus Harbord, Rami Eliakim, Dominik Bettenworth, Konstantinos Karmiris, Konstantinos Katsanos, Uri Kopylov, Torsten Kucharzik, Tamás Molnár, Tim Raine, Shaji Sebastian and 4 more

RetractedErratum issued 2 registry-linked trialsAbstract readConsensus Statement
PubMed Publisher
In one paragraph

Article in Journal of Crohn's & colitis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. It is linked to 2 registered trials, which are not on this map. Cited by 570 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
570citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04165265 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Reduction in Length of Hospitalization in Patients With Acute Severe Ulcerative Colitis Treated With Rescue Therapy With Infliximab by the Use of Web-app Constant-Care. One Year Follow-up, Inclusive Colectomy Rate.

TypeinterventionalSponsorNordsjaellands HospitalRan2019 to 2021Enrolled28ConditionsUlcerative Colitis, TelemedicineArmsConstant-Care
NCT07609810 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

The Effect of Palmitoylethanolamide on the Clinical Outcomes in Ulcerative Colitis Patients

TypeinterventionalSponsorAin Shams UniversityRan2026 to 2029Enrolled60ConditionsUlcerative Colitis (UC)ArmsPalmitoylethanolamide (PEA), Placebo
3 · Its place in the literature

Who cites it

570 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Review
  19. Review
  20. Article

510 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Marcus HarbordImperial College London, and Chelsea and Westminster Hospital, London, UK.
Rami EliakimDepartment of Gastroenterology and Hepatology, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Dominik BettenworthDepartment of Medicine B, University Hospital Münster,Münster, Germany.
Konstantinos KarmirisDepartment of Gastroenterology, Venizeleio General Hospital, Heraklion, Crete, Greece.
Konstantinos KatsanosDepartment of Gastroenterology and Hepatology, University and Medical School of Ioannina, Ioannina, Greece.
Uri KopylovDepartment of Gastroenterology, Tel-Hashomer Sheba Medical Center, and Sackler School of Medicine, Tel Aviv University, Israel.
Torsten KucharzikDepartment of Internal Medicine and Gastroenterology, Hospital Lüneburg, Lüneburg, Germany.
Tamás MolnárFirst Department of Medicine, University of Szeged, Szeged, Hungary.
Tim RaineDepartment of Medicine, University of Cambridge, Cambridge, UK.
Shaji SebastianIBD Unit, Hull & East Yorkshire NHS Trust, Hull, UK.
Helena Tavares de SousaGastroenterology Department, Algarve Hospital Center; Biomedical Sciences & Medicine Department, University of Algarve, Faro, Portugal.
Axel DignassDepartment of Medicine I, Agaplesion Markus Hospital, Frankfurt/Main, Germany.
Franck CarbonnelDepartment of Gastroenterology, CHU Bicêtre, Université Paris Sud, Paris, France.
European Crohn’s and Colitis Organisation [ECCO]

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adrenal Cortex HormonesAnti-Inflammatory Agents, Non-SteroidalBiological ProductsColitis, UlcerativeColon, DescendingColon, SigmoidDrug Therapy, CombinationEvidence-Based MedicineGastrointestinal AgentsHumansImmunosuppressive AgentsMaintenance ChemotherapyMesalamineProctitisRemission InductionTumor Necrosis Factor-alphaAdrenal Cortex HormonesAnti-Inflammatory Agents, Non-SteroidalBiological ProductsGastrointestinal AgentsImmunosuppressive AgentsMesalamineTumor Necrosis Factor-alpha

Identifiers

PMID28513805

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.